WELCOME TO THE SHIMAMURA LAB
|
The Shimamura laboratory focuses on the forefront of translational lung cancer research, utilizing high-quality in vitro and in vivo models to evaluate novel therapeutics. The laboratory is actively collaborating with Dr. Ian Papautsky's Lab in the College of Engineering and Medicine at the University of Illinois Chicago and Dr. Julian Carretero Asunción's Lab at the University of València, Spain. Dr. Takeshi Shimamura's laboratory is a part of the research arm of the Department of Surgery (Chair: Dr. Enrico Benedetti), Cardiothoracic Division (Chief: Dr. Malek Massad) in the College of Medicine at the University of Illinois Chicago. Dr. Shimamura is also a research member of the University of Illinois Cancer Center. |
THE LAB OBJECTIVES
|
The Shimamura laboratory focuses on three key objectives:
1. Providing dynamic research opportunities for aspiring lung cancer researchers. 2. Conducting translational basic science research projects that address the needs of lung cancer patients. 3. Collaborating with researchers from various academic disciplines and industry to explore innovative strategies for assessing lung cancer and developing cutting-edge therapies. |
CURRENT LAB NEWS
June 21, 2024: Dr. Pulido won 1st place for her research poster on applying CHAMP technology (Ranok Therapeutics) to treat resistance to KRAS(G12D) inhibitors at the 37th Annual Great Lakes Chapter American Society for Pharmacology and Experimental Therapeutics (GLC ASPET) Meeting at Rosalind Franklin University of Medicine and Science.
The Free to Breathe walk through the Lung Cancer Research Foundation (LCRF) is an impactful experience, dedicated to building awareness and funding vital research programs to increase lung cancer survival.
Please consider donating to the Shimamura Lab walk team!
Our work is supported by the following funding agencies:
|
|
|
|
